Abstract
Mucopolysaccharidosis (MPS) and Mucolipidosis (ML) share common phenotypes (coarse facial features, organomegaly, dysostosis multiplex) despite having different molecular basis. Thus, they pose great diagnostic challenge to treating clinicians. Differentiating between the two conditions requires a battery of tests from screening to molecular diagnosis. Besides discussing differential diagnosis of MPS like features with negative urinary Glycosaminoglycans (GAG), the authors also discuss the utility of p-nitrocatechol sulphate based chemical test as an important screening tool, besides establishing molecular basis in index case.
References
Tiede S, Storch S, Lübke T, et al. Mucolipidosis II is caused by mutations in GNPTA encoding the alpha/beta GlcNAc-1-phosphotransferase. Nat Med. 2005;11:1109–12.
Paik KH, Song SM, Ki CS, et al. Identification of mutations in the GNPTA (MGC4170) gene coding for GlcNAc-phosphotransferase alpha/beta subunits in Korean patients with mucolipidosis type II or type IIIA. Hum Mutat. 2005;26:308–14.
Sheth J, Mistri M, Kamate M, et al. Diagnostic strategy for mucolipidosis II/III. Indian Pediatr. 2012;49:975–7.
Fuller M, Tucker JN, Lang DL, et al. Screening patients referred to a metabolic clinic for lysosomal storage disorders. J Med Genet. 2011;48:422–5.
Cury GK, Matte U, Artigalás O, et al. Mucolipidosis II and III alpha/beta in Brazil: analysis of the GNPTAB gene. Gene. 2013;524:59–64.
Aggarwal S, Coutinho MF, Dalal AB, Mohamed Nurul Jain SJ, Prata, MJ, Alves S. Prenatal skeletal dysplasia phenotype in severe MLII alpha/beta with novel GNPTAB mutation. Gene. 2014;542:266–8.
Encarnação M, Lacerda L, Costa R, et al. Molecular analysis of the GNPTAB and GNPTG genes in 13 patients with mucolipidosis type II or type III - identification of eight novel mutations. Clin Genet. 2009;76:76–84.
Coutinho MF, Santos Lda S, Girisha KM, et al. Mucolipidosis type II α/β with a homozygous missense mutation in the GNPTAB gene. Am J Med Genet A. 2012;158A:1225–8.
Nampoothiri S, Yesodharan D, Sainulabdin G, et al. Eight years experience from a skeletal dysplasia referral center in a tertiary hospital in southern India: a model for the diagnosis and treatment of rare diseases in a developing country. Am J Med Genet A. 2014;164A:2317–23.
Contributions
AS collected information, made diagnosis and wrote the manuscript; RP, AKG, AniS did literature search and helped in drafting the manuscript; SA, MFC did molecular testing and analysed the results; SK and OPM did critical evaluation of manuscript and gave final approval. OPM will act as guarantor for the paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
None.
Source of Funding
Coutinho MF is grantee from the FCT (SFRH/BPD/101965/2014).
Rights and permissions
About this article
Cite this article
Singh, A., Prasad, R., Gupta, A.K. et al. I Cell Disease (Mucolipidosis II Alpha/Beta): From Screening to Molecular Diagnosis. Indian J Pediatr 84, 144–146 (2017). https://doi.org/10.1007/s12098-016-2243-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-016-2243-7